The OCT New England conference brought together a number of high level professional from a number of pharma, biotech and medical device companies who work in operations and outsourcing in clinical trials. The event focused primarily on rare and orphan disease in 2016 with a popular panel discussion on the pharma and biotech stream on the second day; discussing strategic ways to conduct clinical trials to tackle this area.
Glenn Kerkhof is Executive Chairman of George Clinical. Glenn has over 27 years’ experience in the contract research or drug development industry and joined George Clinical from Chiltern, where he was Chief Executive Officer. Before Chiltern, Glenn served as Vice President, Clinical Services for Charles River Laboratories, and as Vice President, Clinical Europe for Inveresk Research. Also, he is a non-executive director of Immunoglobal Pty. Ltd and his previous directorships include Cell Care Pty. Ltd. Glenn, based in Melbourne, works closely with the executive team to formulate and execute George Clinical’s global strategy.
Meet with George Clinical! Contact us to schedule a time now.
